Because the mTOR signaling pathway, which is critically involved in BP regulation via control of oxidative stress, immune response and metabolism [62], was enriched in patients with OSA and hypertension compared to OSA without hypertension, the authors postulate a role of this pathway in OSA-related hypertension. This evidence concerns the gene MTOR and hypertensive disorder.